Approval · Notice of Compliance 4499 · 1996
TRANDATE: Notice of Compliance 4499
Issued March 12, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4499
- Date
- March 12, 1996
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antihypertensive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRANDATE | 02212250 | — |
| TRANDATE | 02212269 | — |
| TRANDATE | 02212242 | — |
Medicinal ingredients
- LABETALOL HCL 100 MG per TAB
- LABETALOL HCL 200 MG per TAB
- LABETALOL HCL 5 MG per ML